Ex vivo-generated human CD1c+ regulatory B cells by a chemically defined system suppress immune responses and alleviate graft-versus-host disease.
Bao Y, Liu J, Li Z, Sun Y, Chen J, Ma Y, Li G, Wang T, Liu H, Zhang X, Yan R, Yao Z, Guo X, Fang R, Feng J, Xia W, Xiang AP, Chen X.
Bao Y, et al. Among authors: xia w.
Mol Ther. 2024 Oct 26:S1525-0016(24)00686-5. doi: 10.1016/j.ymthe.2024.10.026. Online ahead of print.
Mol Ther. 2024.
PMID: 39489917
Free article.